Literature DB >> 22320379

Oxidative stress and persistent pulmonary hypertension of the newborn treated with inhaled nitric oxide and different oxygen concentrations.

Eloisa Gitto1, Salvatore Pellegrino, Salvatore Aversa, Carmelo Romeo, Giuseppe Trimarchi, Ignazio Barberi, Maria Pia Calabró, Carmelo Damiano Salpietro, Russell J Reiter.   

Abstract

OBJECTIVES: The aim of this study was to determine the effects of inhaled NO with different oxygen concentrations on the inflammatory cascade in newborns with hypoxic respiratory failure secondary to persistent pulmonary hypertension.
METHODS: 60 newborns received iNO and 30 of them received an initial oxygen concentration of 45% (group 1), while the other 30 newborns received an initial oxygen concentration of 80% (group 2). The levels of inflammatory cytokines (IL-6, IL-8, TNF-α) were measured. The clinical outcome was also recorded.
RESULTS: The findings show that interleukin concentrations (IL-6, IL-8, TNF-α) were significantly decreased between 0 and 72 hours (p < 0.01) in the newborns exposed to initial oxygen concentration of 45% and significantly increased in the other group.
CONCLUSIONS: When inhaled, NO was co-administered with concentration of O(2) <45%, anti-inflammatory responses occurred, in accord with evidence in the published literature. The benefits of iNO on the clinical outcome in the current study demonstrate that inhaled NO in both groups was associated with improved short-term oxygenation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22320379     DOI: 10.3109/14767058.2012.663020

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  4 in total

Review 1.  Inflammasomes: a novel therapeutic target in pulmonary hypertension?

Authors:  Tara Elizabeth Scott; Barbara K Kemp-Harper; Adrian J Hobbs
Journal:  Br J Pharmacol       Date:  2018-06-27       Impact factor: 8.739

2.  Association of unit-wide oxygen saturation target on incidence of pulmonary hypertension in very low birthweight premature infants.

Authors:  U Kanaan; B Srivatsa; J Huckaby; M Kelleman
Journal:  J Perinatol       Date:  2017-10-19       Impact factor: 2.521

Review 3.  Portal hypertension as immune mediate disease.

Authors:  Sara Manti; Lucia Marseglia; Gabriella D'Angelo; Martina Filippelli; Caterina Cuppari; Eloisa Gitto; Claudio Romano; Teresa Arrigo; Carmelo Salpietro
Journal:  Hepat Mon       Date:  2014-06-07       Impact factor: 0.660

Review 4.  Factors to Consider to Study Preductal Oxygen Saturation Targets in Neonatal Pulmonary Hypertension.

Authors:  Heather Siefkes; Sherzana Sunderji; Jessica Vaughn; Deepika Sankaran; Payam Vali; Pranjali Vadlaputi; Sage Timberline; Avni Bhatt; Daniel Tancredi; Satyan Lakshminrusimha
Journal:  Children (Basel)       Date:  2022-03-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.